Edition:
United States

miRagen Therapeutics Inc (MGEN.OQ)

MGEN.OQ on NASDAQ Stock Exchange Capital Market

6.39USD
4:00pm EDT
Change (% chg)

$-0.10 (-1.54%)
Prev Close
$6.49
Open
$6.47
Day's High
$6.61
Day's Low
$6.33
Volume
20,840
Avg. Vol
89,922
52-wk High
$15.79
52-wk Low
$5.01

Chart for

About

Miragen Therapeutics, Inc., formerly Signal Genetics, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics with a specific focus on microRNAs and their role in diseases where there is a high unmet medical need. Its clinical product... (more)

Overall

Beta: 1.29
Market Cap(Mil.): $199.14
Shares Outstanding(Mil.): 30.17
Dividend: --
Yield (%): --

Financials

  MGEN.OQ Industry Sector
P/E (TTM): -- 185.16 33.25
EPS (TTM): -1.50 -- --
ROI: -79.78 -0.71 13.13
ROE: -- -2.76 14.96

BRIEF-Miragen Therapeutics Reports Qtrly ‍loss Per Share $0.29​

* MIRAGEN THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Mar 14 2018

BRIEF-Miragen Therapeutics Prices Public Offering Of Common Stock

* MIRAGEN THERAPEUTICS, INC. PRICES PUBLIC OFFERING OF COMMON STOCK

Feb 08 2018

BRIEF-miRagen Therapeutics Announces Proposed Public Offering Of Common Stock

* MIRAGEN THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

Feb 05 2018

BRIEF-Miragen Therapeutics reports third quarter financial results

* Miragen Therapeutics reports third quarter 2017 financial results and provides corporate update

Nov 08 2017

Earnings vs. Estimates